This sequencing research panel targets known gene fusion transcripts for the ALK, RET, ROS1, and NTRK genes.
This research panel targets over 70 known lung cancer-related fusion transcripts for the ALK, RET, ROS1, and NTRK genes.
AmpliSeq for Illumina Community Panels are made-to-order. We provide the designs for your convenience; however, they do not have associated performance metrics. For predesigned and tested content, view AmpliSeq for Illumina Ready-to-Use Panels.
AmpliSeq for Illumina Community Panels contain content selected and designed with input from leading disease researchers. You can order this community panel as is, or customize the panel to meet your needs, using DesignStudio software to add or remove genes and amplicons.
| Input quantity | 1–100 ng; recommended 10 ng per pool |
|---|---|
| Method | Amplicon sequencing |
| Nucleic acid type | RNA |
| Number of amplicons | 85 total (1 pool) |
| Specialized sample types | FFPE tissue |
| Species category | Human |
| Technology | Sequencing |
In addition to the community panel, you will also need an AmpliSeq Library PLUS kit and index adapters.
AmpliSeq™ RNA Fusion Lung Cancer Research Panel for Illumina®
20032798
Targeted custom amplicon panel optimized for specific targets or genomic content of interest. Library PLUS and index adapters sold separately.
List Price:
Discounts:
Showing of
Product
Qty
Unit Price
Product
Catalog ID
Quantity
Unit price
Advanced chemistry, optics, and informatics combine to deliver exceptional speed and data quality, outstanding throughput and scalability.
Optimized reagent kit that provides increased cluster density and read length, improving sequencing quality scores compared to earlier versions.
Enable CGP with a large pan-cancer panel covering all major variant classes plus gene signatures (TMB, MSI, and HRD) from FFPE tissue.
A fast, integrated workflow for preparing libraries for use in a wide range of sequencing applications.
Reach out for information about our products and services, or get answers to questions about our technology.
Your email address is never shared with third parties.
